Mineralys Therapeutics, Inc.

MLYS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Aug 11, 2026 8-K
144 Aug 10, 2026
SCHEDULE 13G/A Aug 6, 2026
4 Jul 23, 2026 FORM 4
144 Jul 21, 2026
4 Jul 20, 2026 FORM 4
144 Jul 17, 2026
4 Jul 15, 2026 FORM 4
4 Jul 15, 2026 FORM 4
144 Jul 15, 2026
144/A Jul 14, 2026
144 Jul 13, 2026
144 Jul 13, 2026
4 Jul 10, 2026 FORM 4
144 Jul 9, 2026
4 Jun 30, 2026 FORM 4
4 Jun 30, 2026 FORM 4
144 Jun 30, 2026
144 Jun 29, 2026
4 Jun 17, 2026 FORM 4
4 Jun 17, 2026 FORM 4
144 Jun 17, 2026
144 Jun 17, 2026
144 Jun 15, 2026
4 Jun 12, 2026 FORM 4
← Newer Page 2 of 17 · 405 filings Older →